Medable Adds Generative AI to Simplify and Speed Up Clinical Trials

Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows. The new feature, called Medable AI, simplifies study builds and reduces electronic Clinical Outcome Assessment (eCOA) generation times from days to seconds.

Medable AI is reportedly the first use of generative AI in clinical trial study design. It automates repetitive tasks, which are said to shorten time to First Patient In (FPI) and improve transparency and control for sponsors and clinical research organizations (CROs).

See also: 11 Notable Companies Enabling Decentralized Clinical Trials

Medable AI includes features such as instant digital conversion of existing assessments and a ChatGPT-like interface for editing and scaling assessments. According to Medable, these tools can reduce the time needed to complete multiple eCOAs for a trial to less than 30 minutes, compared to the days this process typically takes.

Tim Smith, Chief Technology Officer at Medable, stated:

“We aim to remove hurdles to digital and decentralized clinical trials by automating study builds and improving efficiency.”

In September, we sat down with Tim for an interview to discuss their approach in "Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency".

Medable reports its platform has been used in more than 300 decentralized and hybrid trials across 70 countries, involving over one million patients. Customers have seen 90% adherence rates for eCOAs and reported up to 50% cost savings in trials.

A study by Tufts CSDD cited financial benefits of decentralized trials, with returns of up to 13 times the initial investment for Phase II trials and $39 million ROI for Phase III trials on an average $1.5M investment.

Medable AI is part of a broader strategy to increase the speed and accessibility of clinical trials. The company states that the AI-powered tools will be available on the Google Cloud Marketplace in December 2024.

Medable will demonstrate the platform at the Decentralized Trials and Research Alliance’s (DTRA’s) Annual Meeting on Nov. 15, including a session at 3:15 PM.

Cover photo: Volha Rahalskaya

Topics: HealthTech